ReviewGenetic control of autoimmunity in type 1 diabetes
References (82)
Cell
(1989)- et al.
Hum. Immunol.
(1985) - et al.
Hum. Immunol.
(1988) - et al.
Hum. Immunol.
(1989) - et al.
Trends Genet.
(1988) - et al.
Hum. Immunol.
(1989) - et al.
Cell
(1989) - et al.
Cell
(1989) - et al.
Immunol. Today
(1988) - et al.
Diabetologia
(1988)
Am. J. Hum. Genet.
Am. J. Hum. Genet.
Genet. Epidemiol.
Genet. Epidemiol.
Genet. Epidemiol.
Genet. Epidemiol.
Genet. Epidemiol.
Am. J. Hum. Genet.
J. Exp. Med.
Diabetes
Diabetes
J. Immunol.
J. Clin. Invest.
Science
Diabetes Arnu.
Diabetologia
Diabetes
Lab. Invest.
J. Immunol.
Diabetes
Nature
J. Immunol.
Diabetes Care
J. Immunol.
EMBO J.
Nature
Diabetologia
Diabetologia
Cited by (66)
Serologic laboratory findings in malignancy
2011, Rheumatic Disease Clinics of North AmericaCitation Excerpt :Also, most reported studies have emphasized the potential diagnostic and prognostic value of autoantibodies against antigens in cancer epithelial cells, whereas autoantibodies identifying stromal tumor autoantigens, which are also potentially valuable diagnostic and prognostic markers, have not received a great deal of attention. An ever increasing number of autoantibodies are being reported in numerous diseases of seemingly different etiology, including type 1 diabetes and many other diseases in which the common denominator seems to be autoimmunity.146–149 There are important lines of evidence suggesting that autoantibodies in cancer sera are not epiphenomena and that they can significantly contribute to the early diagnosis and prognosis of cancer.
Dental infections and atherosclerosis
1999, American Heart JournalAnalysis of MHC Class II antigens in Japanese IDDM by a novel HLA-typing method, hybridization protection assay
1994, Diabetes Research and Clinical PracticePersonality correlates of type 1 diabetes in a national representative sample
2016, Psihologijske Teme